FDA Import Refusal AEK-1199062-6/3/1 — Strides Pharma, Inc.
The FDA refused shipment AEK-1199062-6/3/1 from Strides Pharma, Inc. (United States) on April 29, 2015. The refused product falls under Drugs and Biologics — DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II). Cited charge: 118 This firm has 4 other import refusals on record.
Refusal Details
- Date
- April 29, 2015
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 62OBA24 DILTIAZEM HYDROCHLORIDE (ANTI-HYPERTENSIVE - PART II)
- Charges
- 118